Overview

Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
0
Participant gender:
All
Summary
This study seeks to determine whether varying the dose of insulin and glucose in diabetic patients during coronary bypass surgery will improve outcomes in these patients.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
American Heart Association
Treatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Diabetic CABG patients

Exclusion Criteria:

- Renal and hepatic failure